Keynote II: Evolving Role of Neoadjuvant Immunotherapy in Curative Intent Head and Neck Cancer

This session covers the history of elective nodal irradiation and how doses were originally selected. Also covered will be how these doses changed as the field moved to IMRT. Failure rates in the elective nodal fields is examined. Additionally, recent trials and institutional experiences studying lower doses of ENI is presented.  Finally, practitioners are educated on how to approach borderline or equivocal nodes that do not meet the standard for full dose irradiation. 

Target Audience

This meeting was designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Understand the history of how current elective nodal irradiation doses were established.
  • Understand the data supporting reduced dose elective nodal irradiation.
  • Understand how to recognize and appropriately dose equivocal lymph nodes.

 

 

Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.75 Certificate of Attendance
    This activity was designated for 0.75 AMA PRA Category 1 Credit™.
Course opens: 
02/09/2026
Course expires: 
03/01/2028
Cost:
$0.00
Part of: 
2026 Multidisciplinary Head and Neck Cancers Symposium onDemand
Rating: 
0

All relevant relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.75 Certificate of Attendance
    This activity was designated for 0.75 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.